Ecological validity of walking capacity tests in multiple sclerosis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Stellmann, J P ^a   Neuhaus, A ^b,c   Gotze N ^a   Briken, S ^a   Lederer, C ^b   Schimpl, M ^c   Heesen, C ^a   Daumer, M ^b,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Sylvia Lawry Centre for Multiple Sclerosis Research   (Germany)

^c TRIUM ANALYSIS ONLINE GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

10 METER WALKING TEST; 2 METER WALKING TEST; 6 METER WALKING TEST; ACCELEROMETRY; ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; ECOLOGICAL VALIDITY; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MIDDLE AGED; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; WALKING; WALKING CAPACITY TEST; WALKING SPEED; AGED; EXERCISE TEST; PATHOPHYSIOLOGY;

ADULT; AGED; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; WALKING;

EID: 84928150192     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123822     Document Type: Article

References (37)

1. Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM (2008) Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler 14: 988-991. doi: 10.1177/1352458508088916 PMID: 18505775
2. Hobart J, Riazi A, Lamping D, Fitzpatrick R, Thompson A (2003) Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology 60: 31. PMID: 12525714
3. Paltamaa J, Sarasoja T, Wikström J, Mälkiä E (2006) Physical functioning in multiple sclerosis: a population-based study in central Finland. J Rehabil Med 38: 339-345. doi: 10.1080/16501970600731537 PMID: 17067966
4. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 14-44. PMID: 6681888
5. Cohen JT (2010) Walking speed and economic outcomes for walking- impaired patients with multiple sclerosis. Expert Rev Pharmacoeconomics Outcomes Res 10: 595-604. doi: 10.1586/erp.10.60 PMID: 20950074
6. Wens I, Dalgas U, Stenager E, Eijnde BO (2013) Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review. Mult Scler J 19: 1556-1564. doi: 10.1177/1352458513504252 PMID: 24048545
7. Kaltenbach G, Berthel M, Lonsdorfer J, Vogel T, Brechat P, Lepre P (2009) Health benefits of physical activity in older patients: a review. Int J Clin Pr 63: 303-320. doi: 10.1111/j.1742-1241.2008.01957.x
8. Gijbels D, Eijnde BO, Feys P (2011) Comparison of the 2- and 6-minute walk test in multiple sclerosis. Mult Scler 17: 1269-1272. doi: 10.1177/1352458511408475 PMID: 21642370
9. Kieseier BC, Pozzilli C (2012) Assessing walking disability in multiple sclerosis. Mult Scler 18: 914-924. doi: 10.1177/1352458512444498 PMID: 22740603
10. Gijbels D, Dalgas U, Romberg A, de Groot V, Bethoux F, Vaney C, et al. (2012) Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set. Mult Scler 18: 364-371. doi: 10.1177/1352458511420598 PMID: 21952098
11. Albrecht H, Wotzel C, Erasmus LP, Kleinpeter M, Konig N, Pollmann W (2001) Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter. Mult Scler 7: 105-109. doi: 10.1177/135245850100700206 PMID: 11424630
12. Feys P, Gijbels D, Romberg A, Santoyo C, Gebara B, de Noordhout B, et al. (2012) Effect of time of day on walking capacity and self-reported fatigue in persons with multiple sclerosis: a multi-center trial. Mult Scler 18: 351-357. doi: 10.1177/1352458511419881 PMID: 21969239
13. Coleman C, Sobieraj D, Marinucci L (2012) Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis. Curr Med Res Opin 28: 49-56. doi: 10.1185/03007995.2011.639752 PMID: 22073939
14. Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, et al. (2010) A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann Neurol 68: 494-502. doi: 10.1002/ana.22240 PMID: 20976768
15. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, et al. (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373: 732-738. doi: 10.1016/S0140-6736(09)60442-6 PMID: 19249634
16. Schimpl M, Moore C, Lederer C, Neuhaus A, Sambrook J, Danesh J, et al. (2011) Association between Walking Speed and Age in Healthy, Free-Living Individuals Using Mobile Accelerometry-A Cross-Sectional Study. PLoS One 6: e23299. doi: 10.1371/journal.pone.0023299 PMID: 21853107
17. Motl RW, Weikert M, Suh Y, Sosnoff JJ, Pula J, Soaz C, et al. (2011) Accuracy of the actibelt accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis. Gait Posture: 1-5. doi: 10.1016/j.gaitpost.2011.09.005 PMID: 21944877
18. Schimpl M, Lederer C, Daumer M (2011) Development and validation of a new method to measure walking speed in free-living environments using the actibelt1 platform. PLoS One 6: e23080. doi: 10.1371/journal.pone.0023080 PMID: 21850254
19. Schlesinger S, Neuhaus A, Thiele A, Kippnich M, Rashid A, Griewing B, et al. Sind Mobilitätseinschränkungen bei Patienten mit Multipler Sklerose messbar? Klinische Neurophysiologie. 2011. pp. 17-21. doi: 10.1055/s-0031-1271750
20. Stellmann J-P, Neuhaus A, Stolle C, Goetze N, Soaz C, Schimpl M, et al. (2011) Physical activity in multiple sclerosis: association of 3D-accelerometry data with subjective and rater-based disease status. Mult Scler 17: S13.
21. Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T, et al. (2010) Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler 16: 618-626. doi: 10.1177/1352458510361357 PMID: 20207785
22. Motl RW, Pilutti L, Sandroff B, Dlugonski D, Sosnoff J, Pula JH (2013) Accelerometry as a measure of walking behavior in multiple sclerosis. Acta Neurol Scand 127: 384-390. doi: 10.1111/ane.12036 PMID: 23240822
23. Daumer M, Thaler K, Kruis E, Feneberg W, Staude G, Scholz M (2007) Steps towards a miniaturized, robust and autonomous measurement device for the long-term monitoring of patient activity: ActiBelt. Biomed Tech (Berl) 52: 149-155. doi: 10.1515/BMT.2007.028 PMID: 17313352
24. Goldman MD, Marrie RA, Cohen JA (2008) Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 14: 383-390. doi: 10.1177/1352458507082607 PMID: 17942508
25. Soaz C, Daumer M (2012) A feasibility study for the integration of 3D accelerometry in fall risk assessment. Biomed Tech (Berl) 57: 165-168. doi: 10.1515/bmt-2012-4415
26. Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 5: 244-250. doi: 10.1177/135245859900500409 PMID: 10467383
27. Savci S, Inal-Ince D, Arikan H, Guclu-Gunduz A, Cetisli-Korkmaz N, Armutlu K, et al. (2005) Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil 27: 1365-1371. doi: 10.1080/09638280500164479 PMID: 16372431
28. R Development Core Team (2010) R: A language and environment for statistical computing.
29. Butte NF, Ekelund U, Westerterp KR (2012) Assessing physical activity using wearable monitors: measures of physical activity. Med Sci Sports Exerc 44: S5-S12. doi: 10.1249/MSS.0b013e3182399c0e PMID: 22157774
30. Sandroff BM, Riskin BJ, Agiovlasitis S, Motl RW (2014) Accelerometer cut-points derived during overground walking in persons with mild, moderate, and severe multiple sclerosis. J Neurol Sci 340: 50-57. doi: 10.1016/j.jns.2014.02.024 PMID: 24635890
31. Moseley AM, Lanzarone S, Bosman JM, Van Loo MA, De Bie RA, Hassett L (2004) Ecological Validity of Walking Speed Assessment After Traumatic Brain Injury A Pilot Study. Lloydia (Cincinnati) 19: 341-348.
32. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW et al. (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132: 919-923. PMID: 3978515
33. Wetzel JL, Fry DK, Pfalzer LA (2011) Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors. Physiother Can 63: 166-180. doi: 10.3138/ptc.2009-62 PMID: 22379256
34. Hobart J, Blight AR, Goodman A, Lynn F, Putzki N (2013) Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS. Neurology. doi: 10.1212/WNL.0b013e31828cf7f3
35. Goldman MD, Motl RW, Scagnelli J, Pula JH, Sosnoff JJ, Cadavid D (2013) Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world. Neurology 81: 1856-1863. doi: 10.1212/01.wnl.0000436065.97642.d2 PMID: 24174581
36. Ekblom-bak E, Ekblom B, Vikström M (2013) The importance of non-exercise physical activity for cardiovascular health and longevity. doi: 10.1136/bjsports-2012-092038 PMID: 24167194
37. Chabrol H, Harrer JU (2012) Comment: Mobile technology in neurology. Neurology 78: 323. doi: 10.1212/WNL.0b013e3182452985 PMID: 22218272